DexCom, Inc. (DXCM)
91.06
+0.24
(+0.26%)
USD |
NASDAQ |
Aug 31, 16:00
91.09
+0.03
(+0.03%)
After-Hours: 20:00
DexCom Cash from Operations (TTM) : 1.749B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.749B |
| March 31, 2026 | 1.782B |
| December 31, 2025 | 1.441B |
| September 30, 2025 | 1.448B |
| June 30, 2025 | 987.70M |
| March 31, 2025 | 964.10M |
| December 31, 2024 | 989.50M |
| September 30, 2024 | 821.70M |
| June 30, 2024 | 891.40M |
| March 31, 2024 | 802.30M |
| December 31, 2023 | 748.50M |
| September 30, 2023 | 747.40M |
| June 30, 2023 | 771.40M |
| March 31, 2023 | 753.90M |
| December 31, 2022 | 669.50M |
| September 30, 2022 | 642.80M |
| June 30, 2022 | 596.90M |
| March 31, 2022 | 485.70M |
| December 31, 2021 | 442.50M |
| September 30, 2021 | 508.70M |
| June 30, 2021 | 409.00M |
| March 31, 2021 | 501.50M |
| December 31, 2020 | 475.60M |
| September 30, 2020 | 447.30M |
| June 30, 2020 | 394.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 304.60M |
| December 31, 2019 | 314.50M |
| September 30, 2019 | 204.50M |
| June 30, 2019 | 166.80M |
| March 31, 2019 | 143.70M |
| December 31, 2018 | 123.20M |
| September 30, 2018 | 130.70M |
| June 30, 2018 | 110.10M |
| March 31, 2018 | 83.00M |
| December 31, 2017 | 92.00M |
| September 30, 2017 | 64.10M |
| June 30, 2017 | 50.90M |
| March 31, 2017 | 56.70M |
| December 31, 2016 | 56.20M |
| September 30, 2016 | 54.20M |
| June 30, 2016 | 48.40M |
| March 31, 2016 | 44.40M |
| December 31, 2015 | 48.00M |
| September 30, 2015 | 45.10M |
| June 30, 2015 | 39.30M |
| March 31, 2015 | 29.40M |
| December 31, 2014 | 23.60M |
| September 30, 2014 | 19.60M |
| June 30, 2014 | 9.80M |
| March 31, 2014 | 4.50M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Abbott Laboratories | 9.905B |
| Insulet Corp. | 511.30M |
| Baxter International, Inc. | 1.319B |
| Globus Medical, Inc. | 910.39M |
| Stryker Corp. | 5.525B |